Hormone testing is only useful when the right markers are drawn at the right time, interpreted against the right reference framework, and then acted on with a specific intervention and a re-testing schedule. Anything short of that is data without a plan. At TrufaMED, hormone testing in Miami Beach is delivered by board-certified physicians inside a Joint Commission-accredited clinical setting — the only such accredited urgent care in Florida — with on-site draws, fasting-window protocols, and longitudinal follow-up built into the concierge and preventive care frameworks.
A comprehensive baseline hormone panel at TrufaMED Miami Beach includes TSH, free T4, free T3, total and free testosterone, estradiol, progesterone, DHEA-S, morning cortisol, SHBG, vitamin D, B12, CBC, and a comprehensive metabolic panel — drawn fasting between 7 and 10 AM, cycle-day dependent for cycling women. Results are reviewed by a physician, not auto-routed. Follow-up labs are scheduled at 6 to 8 weeks after any intervention, then at 3 and 6 months.
Hormones move on daily, weekly, and menstrual cycles. Cortisol is highest within the first hour of waking and is nearly half that value by evening. Testosterone follows a similar diurnal curve in men. Estradiol and progesterone move across the menstrual cycle in a predictable but dramatic arc. TSH has its own subtle diurnal pattern. A hormone lab drawn at 3 PM on a random Tuesday can read meaningfully different than the same lab drawn at 8 AM on a fasted morning.
This is why hormone testing has a protocol. Reference ranges assume standardized draw conditions. If those conditions are not met, the number you get back is not directly comparable to the population data the reference range is built from. TrufaMED’s preventive care program draws hormone panels fasted, in the early morning, and — for cycling women — on a specified cycle day.
The baseline panel is the starting point for any patient entering the hormone testing program. It is not an exhaustive endocrine workup, but it covers the axes that drive the most common symptoms: fatigue, weight change, mood, libido, sleep disruption, cognitive fog, and cycle irregularity.
The thyroid panel at TrufaMED includes TSH (the pituitary signal), free T4 (the storage form), and free T3 (the active form). Many clinics order only TSH. That is inadequate. A patient can have a normal TSH and still be under-converting T4 to T3, producing symptomatic hypothyroidism that the single-marker screen misses. When autoimmune thyroid disease is suspected, TPO and thyroglobulin antibodies are added.
For men, the baseline includes total testosterone, free testosterone, SHBG (sex hormone-binding globulin), and estradiol (yes, men measure estradiol; an over-aromatized testosterone program produces elevated estradiol and its own symptom cluster). LH and FSH are added when low testosterone is confirmed, to distinguish primary testicular failure from secondary (pituitary) hypogonadism. Prolactin is added when LH is unexpectedly low.
For women, the panel depends on menstrual status. Cycling women get estradiol, progesterone, FSH, LH, total and free testosterone, DHEA-S, and SHBG, with draw day specified: day 3 for follicular baseline (FSH, LH, estradiol) and day 21 for mid-luteal progesterone (which confirms ovulation). Perimenopausal women follow a similar schedule with closer attention to FSH trending. Postmenopausal women can draw any day, though morning is still preferred.
Morning cortisol (drawn 7 to 9 AM) captures the peak of the diurnal curve. DHEA-S, the long-half-life adrenal androgen, gives a stable integrated view of adrenal output. When Cushing’s or adrenal insufficiency is in the differential, a 24-hour urine free cortisol or an ACTH-stimulation protocol is added.
Hormone testing without metabolic context is incomplete. Fasting glucose, fasting insulin, and HbA1c build the metabolic picture. HOMA-IR (calculated from fasting glucose and insulin) gives an insulin resistance estimate before HbA1c rises. Leptin can be added in cases of severe obesity or unexplained weight patterns.
Hormones do not move without their cofactors. Vitamin D (25-OH), B12, and ferritin are part of every baseline. Low vitamin D impairs testosterone production and immune function. Low B12 and low ferritin produce fatigue patterns that mimic hypothyroidism. These are easy fixes — but only if they are measured.
Every hormone baseline includes a CBC (for anemia, polycythemia, infection markers) and a comprehensive metabolic panel (liver and kidney function, electrolytes). These anchor safety for any subsequent therapy.
A hormone panel drawn at the wrong time produces misleading results and can trigger unnecessary treatment or miss treatable conditions. The TrufaMED testing services program enforces draw windows.
Fasting. 8 to 12 hours without food. Water is permitted. Medications are continued unless the physician has specified a hold for a specific reason.
Time of day. Morning — between 7 and 10 AM — captures the peak of cortisol and testosterone. Thyroid hormones have a subtler but real diurnal pattern; morning is also preferred.
Cycle day for cycling women. Day 3 (with day 1 as the first day of full menstrual flow) for FSH, LH, and estradiol. Day 21 for mid-luteal progesterone. If a woman has very long cycles, progesterone is drawn approximately seven days before the expected next period.
Exercise and recent illness. A heavy workout in the preceding 24 hours can elevate cortisol and suppress free testosterone. Acute illness elevates CRP and can shift thyroid hormones (non-thyroidal illness syndrome). When possible, draws are scheduled in a baseline-state week.
Lab reports print reference ranges: the statistical 95% interval of the tested population. That is a useful sanity check. It is not the same as an optimal clinical target. A testosterone of 310 ng/dL is technically "normal" but is at the bottom of the adult male population and frequently produces symptoms in a man who ran 600 ng/dL a decade earlier. A TSH of 4.5 mIU/L is inside most reference ranges but typically corresponds to symptomatic hypothyroidism in motivated patients.
TrufaMED physicians interpret results against both frames — the reference range (to rule out disease) and the optimal range (to guide optimization for a patient who is functionally symptomatic). That interpretation is the actual product. A number on a portal is not the same as a physician telling you what it means for the next 90 days.
Testosterone replacement therapy (TRT) is considered when a man has consistent clinical symptoms of hypogonadism (low libido, loss of morning erections, fatigue, loss of muscle mass, depressive symptoms, erectile dysfunction) AND two separate morning total testosterone measurements below approximately 300 ng/dL. Confirmatory markers include free testosterone, LH, FSH, and prolactin. A fertility plan is addressed before initiation — exogenous testosterone suppresses endogenous production and often suppresses sperm counts; men planning future fertility are counseled on alternatives (clomiphene, hCG) and sperm banking.
Once initiated, TRT is monitored with serial testosterone, estradiol, hematocrit (polycythemia risk), and PSA. Formulations include transdermal gels, intramuscular injections, and pellets. The choice is individualized to adherence, bleed tolerance, and clinical response. Fourth-generation options vary in evidence and cost. TrufaMED does not prescribe off-label or anabolic doses.
The modern HRT landscape is very different from the early-2000s WHI-era clinical caution. Current guidelines support HRT for symptom management in appropriately screened perimenopausal and early-postmenopausal women (typically within 10 years of last menstrual period or under age 60), using FDA-approved transdermal estradiol and micronized progesterone when a uterus is present. Compounded formulations are used only when FDA-approved preparations cannot meet clinical need.
Contraindications include active breast or endometrial cancer, unexplained vaginal bleeding, active thromboembolic disease, and advanced liver disease. Relative contraindications include elevated cardiovascular risk, migraine with aura, and family history of certain cancers. The TrufaMED physician reviews risk stratification, screens with mammography and cervical screening on current guidelines, and monitors with serial labs and symptom tracking.
Overt hypothyroidism (elevated TSH with low free T4) is treated with levothyroxine. Subclinical hypothyroidism (elevated TSH with normal free T4) is a clinical judgment: symptom burden, age, cardiovascular risk, pregnancy status, and TPO antibody status all factor in. T3-containing regimens (desiccated thyroid, liothyronine add-on) are considered in selected patients who remain symptomatic on levothyroxine monotherapy despite optimized TSH.
True Addison’s disease and Cushing’s syndrome are rare and require endocrinology-level workup. "Adrenal fatigue" as a standalone diagnosis is not a recognized medical entity; what is usually present is a combination of inadequate sleep, chronic stress physiology, subclinical hypothyroidism, iron deficiency, and vitamin D deficiency. TrufaMED addresses these measurable root causes rather than treating an unmeasurable label.
Patients in these categories are moved to a same-week physician evaluation. Urgent care can bridge the gap when symptoms are acute.
Testing without a follow-up schedule is an expensive snapshot. The TrufaMED protocol:
TrufaMED’s concierge membership folds hormone testing into a structured longitudinal framework: scheduled baseline and quarterly panels, a dedicated physician consultation for interpretation (not a portal message), rapid same-day labs when symptoms shift between scheduled draws, and access to integrated services — IV therapy for micronutrient correction, telehealth for between-visit follow-up, and digital imaging when indicated.
For patients who want a deeper healthspan framework, see our related overview of longevity medicine in Miami Beach and executive physical in Miami Beach.
Before the visit. Cycling women schedule to a cycle day. All patients fast 8 to 12 hours. Medications are continued unless specifically held. Recent heavy training is flagged.
At the visit. Review of symptoms, medical history, family history, current medications and supplements. Blood draw on-site, with same-day processing for most panels and two- to five-day turnaround for specialty markers.
Results consultation. A dedicated physician review — in clinic or via telehealth — walking through the panel, identifying actionable findings, and designing the intervention plan with specific follow-up labs on the calendar.
A baseline hormone panel at TrufaMED typically covers TSH, free T4, free T3, total and free testosterone, estradiol, progesterone, DHEA-S, morning cortisol, SHBG, vitamin D, B12, a CBC, and a comprehensive metabolic panel. Additional markers (IGF-1, LH, FSH, prolactin) are added based on clinical presentation.
Most hormones should be drawn in the morning after an overnight fast. Testosterone and cortisol peak in the early morning. Fasting glucose and insulin require 8 to 12 hours without food. TrufaMED schedules hormone draws between 7 and 10 AM when possible.
Yes. Estradiol and progesterone are menstrual-cycle dependent. Day 3 is typical for FSH, LH, and estradiol (follicular baseline). Day 21 is typical for mid-luteal progesterone to confirm ovulation. Postmenopausal and amenorrheic patients can draw any day.
Reference ranges are statistical: 95% of the tested population falls within them. Optimal ranges are clinical: the narrower band where symptoms typically resolve and long-term risk markers are minimized. A physician reviews both.
Testosterone replacement is considered when a man has consistent symptoms of hypogonadism (low libido, fatigue, loss of muscle mass, erectile dysfunction, mood changes) AND two separate morning total testosterone values below approximately 300 ng/dL, with confirmatory free testosterone and LH/FSH to distinguish primary from secondary hypogonadism.
Bioidentical hormones are molecules chemically identical to those the body produces (estradiol, progesterone, testosterone). They may be FDA-approved commercial preparations or compounded formulations. TrufaMED uses FDA-approved bioidentical preparations whenever possible and monitors all patients with serial labs.
After initiating therapy, labs are typically rechecked at 6 to 8 weeks, then at 3 months, then every 6 months once stable. Men on testosterone also have hemoglobin, hematocrit, and PSA monitored. Women on estrogen require periodic breast and cardiovascular risk review.
Red flags include unexplained weight loss with tachycardia, severe menstrual changes, galactorrhea, new visual field changes with headache, hyperpigmentation with fatigue and hypotension, and progressive gynecomastia in men. These patterns suggest pituitary, adrenal, or thyroid disease and require same-week evaluation.
Standard panels (TSH, testosterone, estradiol, CBC, CMP) ordered within a physician encounter are typically covered when medical indication is documented. Expanded panels, compounded therapy, and concierge visits may be self-pay. TrufaMED accepts most major carriers for eligible labs.
Concierge membership includes scheduled baseline and quarterly panels, physician interpretation in a dedicated consultation rather than a patient-portal message, and rapid protocol adjustments. Members also get same-day labs when symptoms change between scheduled draws.
Begin your hormone assessment. Physician-reviewed. Joint Commission accredited. On-site draws with protocol-correct timing. Learn more about our clinical team, our preventive care program, or book a consult through concierge services.
TrufaMED Urgent Care and Concierge Medicine is located at 9445 Harding Avenue, Surfside, FL 33154 — directly adjacent to Miami Beach. Open Monday to Friday 9 AM to 9 PM, Saturday 11 AM to 11 PM, and Sunday 12 PM to 8 PM. Board-certified physicians on shift every day.
Serving These Areas
Copyright © 2026 TrufaMED Urgent Care
